top of page
.jpg)
STUDY DESIGN
A double-blind, randomized, placebo-controlled clinical study in patients with diagnosed or suspected Small Intestinal Bacterial Overgrowth (SIBO).
A Study in Partnership with Lallemand Health Solutions
Qualifying participants will be provided with a diagnostic breath test for small bacterial overgrowth, complete daily and weekly questionnaires, will follow an 8 week course of probiotics (or placebo), with sampling for microbiome changes at several time points.
Ethics approval ID: HREBA.CTC-23-0061
TO BE ELIGIBLE FOR THE STUDY, YOU MUST MEET AT LEAST THE FOLLOWING CRITERIA
18 - 55 years of AGE
Suffer from bloating, diarrhea or abdominal pain
Follow an 8 week
course of Probiotics
Male or female
Upon enrollment you will receive a diagnostic Breath Test to confirm your eligibility.
Formulation designed for SIBO
note: some participants will receive a placebo
Didn’t find a study that suits you today?
Register to be notified about upcoming studies.
Terms and Conditions: Your information will only be used to contact you about opportunities to join future clinical studies. You can unsubscribe at any time. Your information will not be shared.
bottom of page